METROPOLITAN LIFE INSURANCE CO/NY - ALX ONCOLOGY HLDGS INC ownership

ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 98 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ALX ONCOLOGY HLDGS INC
ValueSharesWeighting
Q2 2023$9,020
-38.8%
1,201
-8.2%
0.00%
-100.0%
Q4 2022$14,741
+17.8%
1,3080.0%0.00%0.0%
Q3 2022$12,518
-40.4%
1,308
+5.3%
0.00%0.0%
Q1 2022$20,990
-81.2%
1,242
-76.1%
0.00%
-50.0%
Q4 2021$111,898
-70.9%
5,2070.0%0.00%
-66.7%
Q3 2021$384,589
+5.3%
5,207
+5.1%
0.01%
+20.0%
Q1 2021$365,308
+41.2%
4,954
+65.1%
0.01%
+25.0%
Q4 2020$258,686
+128.4%
3,0010.0%0.00%
+100.0%
Q3 2020$113,2583,0010.00%
Other shareholders
ALX ONCOLOGY HLDGS INC shareholders Q2 2022
NameSharesValueWeighting ↓
venBio Partners LLC 9,699,925$109,318,15533.89%
Vivo Capital, LLC 4,220,048$47,5605.48%
Logos Global Management LP 2,349,600$26,479,9923.10%
Samsara BioCapital, LLC 262,786$2,961,5980.64%
Orbimed Advisors 2,871,000$32,356,1700.62%
Pier Capital, LLC 271,848$3,063,7270.50%
Cormorant Asset Management, LP 612,079$6,8980.46%
Nan Fung Group Holdings Ltd 41,950$472,7770.33%
Artal Group S.A. 500,000$5,6350.32%
Redmile Group, LLC 607,470$6,846,1870.28%
View complete list of ALX ONCOLOGY HLDGS INC shareholders